Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Cystic Fibrosis (CF) Therapeutics Market Value Growth And Long-Term Outlook
The cystic fibrosis (cf) therapeutics market has demonstrated robust growth in recent years. Its valuation is projected to rise from $8.34 billion in 2025 to $8.91 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.8%. The growth experienced in prior periods can be attributed to factors such as the high prevalence of cystic fibrosis, the limited availability of early diagnostic tools, the reliance on traditional mucolytic therapies, the gradual adoption of CFTR modulators, and variations in regional healthcare infrastructure.
The cystic fibrosis (cf) therapeutics market size is projected to experience substantial expansion over the next few years. It is anticipated to grow to $11.72 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This expected increase during the forecast period can be attributed to several factors such as advancements in gene therapy, a greater embrace of digital health solutions, an increase in precision medicine applications, the broadening of pediatric cf treatment programs, and growing financial commitments to therapeutics for rare diseases. Prominent trends for the upcoming period include personalized cystic fibrosis therapies, sophisticated pulmonary drug delivery methods, research into gene editing and cftr gene therapy, solutions for patient adherence and remote monitoring, and the development of orphan drugs for uncommon cf mutations.
Get A Free Sample Report With In-Depth Market Insights:
Cystic Fibrosis (CF) Therapeutics Market Growth Factors: What’s Supporting Expansion?
The increasing number of patients diagnosed with cystic fibrosis is projected to propel the expansion of the cystic fibrosis (CF) therapeutics market moving forward. Cystic fibrosis (CF) is a hereditary condition that severely damages the body’s lungs, digestive system, and other vital organs. Cystic fibrosis therapeutics are utilized to manage the disorder by making the mucus in the lungs thinner and easier to expel. Consequently, an increase in the number of individuals suffering from cystic fibrosis is expected to boost the cystic fibrosis (CF) therapeutics market. For instance, in 2023, according to the Cystic Fibrosis Foundation, a U.S.-based nonprofit, non-governmental organization (NGO), the CF Patient Registry contained 32,547 individuals in 2022, which grew to 33,288 in 2023, indicating an increase of nearly 2.3%. Therefore, the rising number of patients affected by cystic fibrosis is driving the growth of the cystic fibrosis (CF) therapeutics market.
Cystic Fibrosis (CF) Therapeutics Market Segments: Where Is Growth Concentrated?
The cystic fibrosis (cf) therapeutics market covered in this report is segmented –
1) By Drug Class: Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators
2) By Route Of Administration: Oral, Inhaled
3) By Treatment Method: Medication, Devices
Subsegments:
1) By Pancreatic Enzyme Supplements: Lipase, Amylase, Protease
2) By Mucolytics: Dornase Alfa (Pulmozyme), Hypertonic Saline
3) By Bronchodilators: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Anticholinergics
4) By CFTR Modulators: Ivacaftor, Lumacaftor Or Ivacaftor (Orkambi), Tezacaftor Or Ivacaftor (Symdeko), Elexacaftor Or Tezacaftor Or Ivacaftor
Cystic Fibrosis (CF) Therapeutics Market Industry Trends: What’s Reshaping Demand?
Major companies within the cystic fibrosis (CF) therapeutics market are advancing treatment and patient care through innovative solutions, such as the cystic fibrosis innovation hub network. These networks aim to speed up research, enhance treatment possibilities, and foster greater cooperation in creating new therapies for CF patients. The cystic fibrosis innovation hub network itself functions as a collaborative platform or initiative specifically designed to accelerate the research and development of novel cystic fibrosis (CF) treatments. For instance, in October 2024, LifeArc, a UK-based charity and life sciences company dedicated to translating scientific research into effective healthcare solutions, launched the first Cystic Fibrosis Innovation Hub Network in the UK. This network is structured to improve research and development for cystic fibrosis (CF) treatments, promoting collaboration among healthcare providers, researchers, and patients. It was introduced as part of a wider effort to accelerate innovation in cystic fibrosis therapies, with a focus on identifying new routes for drug development and enhancing patient outcomes.
Cystic Fibrosis (CF) Therapeutics Market Key Participants And Competitive Landscape
Major companies operating in the cystic fibrosis (cf) therapeutics market are Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici SpA, PTC Therapeutics LIMITED, Genentech Inc., Alaxia, AstraZeneca, Beyond Air Inc., Pfizer Inc., Alcresta Therapeutics Inc., Laurent Pharmaceuticals, Nestlé HealthScience, Pharmaxis, Bayer AG, AbbVie Inc., Novartis AG, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc, ProQR Therapeutics N.V., Enterprise Therapeutics Ltd. , Corbus Pharmaceuticals Holdings Inc, Eloxx Pharmaceuticals , Translate Bio Inc, Zambon S.p.A
View The Full Cystic Fibrosis (CF) Therapeutics Market Report:
Cystic Fibrosis (CF) Therapeutics Market Leading Geography: Which Region Contributes The Most Revenue?
North America was the largest region in the cystic fibrosis (CF) therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the cystic fibrosis (CF) therapeutics market during the forecast period. The regions covered in the cystic fibrosis (cf) therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
